Acetylsalicylic Acid not checked
ECRI bv · B01AC06
FollowEvery change as it happens, and a Monday email
Stage
No active trials
Next date
None yet
Trials
50 active
60 in total · 59 in the EU
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “Comparison of 1 month of ticagrelor and aspirin followed by 23 months of ticagrelor monotherapy versus 12 months of standard dual anti platelet therapy (DAPT) followed by aspirin monotherapy”In the company’s words, NCT01813435 on ClinicalTrials.gov
- Tested for
- Coronary Artery Disease (CAD)
- Main trialPhase 3
- “After a stent procedure, it is common practice to prescribe anti-platelet medication to prevent the blood from clotting. The main objective of this study is to determine if there is a better medication strategy to prevent blood from clotting and at the same time minimising the number of complications. There are two medication strategies: * Study group: Dual anti-platelet therapy (ticagrelor combined with aspirin) for 1 month, and then ticagrelor alone for another 23 months OR * Control group: Standard treatment, being dual anti-platelet therapy (ticagrelor or clopidogrel combined with…”In the company’s words, NCT01813435 on ClinicalTrials.gov
- Other names
- Aspirin · B01AC06
Other drugs for Coronary Artery Disease (CAD)
- XTR004Sinotau Pharmaceutical Group · Phase 3
- EA-230EBI Anti Sepsis BV · Phase 3
- ObicetrapibNewAmsterdam Pharma · Phase 3
- Bempedoic acid/ezetimibeDaiichi Sankyo · Phase 3
- ZiltivekimabNovo Nordisk · Phase 3
- RetatrutideEli Lilly · Phase 3
Coming up0
No dates coming up.
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials60
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Completed | 9 Nov 2015 | GLOBAL LEADERS: A Clinical Study Comparing Two Forms of Anti-platelet Therapy After Stent Implantation | |
| Phase 4Authorised | not given | Reduced antithrombotic strategy for high bleeding risk patients with myocardial infarction treated with percutaneous coronary intervention - The Dan-DAPT trial | |
| Phase 3/4Authorised | not given | Aspirin for the Prevention of Preeclampsia and Pregnancy outcomes in nulliparous women after Assisted Reproductive Technology. APPART trial | |
| Phase 3Authorised | not given | A Phase III double-blind placebo-controlled Randomised Trial of Aspirin on Recurrence and Survival in Colon Cancer Patients | |
| Phase 3Authorised | not given | A Phase III double-blind placebo-controlled Randomised Trial of Aspirin on Recurrence and Survival in Colon Cancer Patients. | |
| Phase 3Authorised | not given | Aspirin versus placebo in twin pregnancies for preeclampsia prevention: A multicentre, randomised, double-blind, placebo-controlled trial (ASPRE-T) | |
| Phase 4Authorised | not given | Drug-Coated Balloon in Anticoagulated and Bleeding Risk Patients Undergoing PCI (DEBATE) | |
| Phase 4Authorised | not given | Less Bleeding by Omitting Aspirin in Non-ST-segment Elevation Acute Coronary Syndrome Patients | |
| Phase 4Ended | not given | Aspirin to prevent cardiovascular events in patients with community-acquired pneumonia or influenza | |
| Phase 3Authorised | not given | A Phase III trial of acetylsalicylic acid and atorvastatin in patients with castrate-resistant prostate cancer (PEACE 4) | |
| Phase 2/3Authorised | not given | Short versus long antiplatelet therapy after TAVI | |
| Phase 4Authorised | not given | Dual antiplatelet therapy with ticagrelor and acetylsalicylic acid (ASA) vs. ASA only after isolated coronary artery bypass grafting in patients with acute coronary syndrome (TACSI trial) | |
| Phase 3Authorised | not given | ASPAPY - Aspirin in acute pneumonia in the elderly: a multicenter, double-blind, randomized, placebo-controlled trial | |
| Phase 3Authorised | not given | Add-Aspirin: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non metastatic solid tumours. | |
| Phase 3/4Authorised | not given | CLEAR-PATH A randomized placebo-controlled double-blind trial studying the effect of single antiplatelet therapy (clopidogrel) versus dual antiplatelet therapy (clopidogrel/acetylsalicylic acid) on the occurrence of atherothrombotic events following lower extremity peripheral transluminal angioplasty | |
| Phase 2Authorised | not given | A randomized trial of multi-factorial primary prevention in high risk subjects candidate to a lung cancer early detection CT program | |
| Phase 3Authorised | not given | SERORL Effect of aspirin and folic acid for sudden sensorineural hearing loss | |
| Phase 3Authorised | not given | A randomized double-blind placebo-controlled study with ASA treatment in colorectal cancer patients with mutations in the PI3K signaling pathway | |
| Phase 2/3Ended | not given | Long-term aspirin therapy as a predictor of decreased susceptibility to SARSCoV-2 infection in aspirin-exacerbated respiratory disease | |
| Phase 3Authorised | not given | Treatment of acute ischemic stroke due to occlusion of a large vessel by mechanical thrombectomy in patients with unknown onset or not meeting the criteria for CT eligibility (ASPECTS <6) based on MRI criteria (DWIFLAIR mismatch) | |
| Phase 3/4Ended | not given | Randomized comparison of short versus 12 months prasugrel plus aspirin in patients with acute coronary syndromes treated with percutaneous coronary intervention and everolimus-eluting stents | |
| Phase 2Authorised | not given | Effect of obesity on the acetylation of COX1 and COX2 by aspirin as a biomarker of its effectiveness in chemoprevention and therapy in colon cancer: A Phase II Clinical Trial | |
| Phase 3Not authorised | not given | Targeting inflammation to reduce 90-day and 1-year postoperative severe morbidity in patients with unfavorable inflammatory profile undergoing oncologic surgery (POST-CARE trial) | |
| Phase 2Authorised | not given | Targeting inflammation to reduce 90-day and 1-year postoperative severe morbidity in patients with unfavorable inflammatory profile undergoing oncologic surgery (POST CARE Trial) | |
| Phase 4Authorised | not given | Head-to-head compaRison of single versus dual antiplatelet treatMent strategY after percutaneous left atrial appenDage closure: A MULticenter, randomizEd sTudy. The ARMYDA-AMULET study | |
| Phase 3Authorised | not given | Impact of Exercise and Mediterranean diet vs Aspirin on live-birth rate and cardiovascular programming in In Vitro Fertilization (MEDITATE-IVF): a Randomized Study. | |
| Phase 4Authorised | not given | COMPARE STEMI ONE- Comparison Of reduced DAPT followed by P2Y12 inhibitor Monotherapy with Prasugrel vs tAndard Regimen in STEMI patients treated with OCT-guided vs aNgio-guided completE revascularization. | |
| Phase 3Authorised | not given | French prospective randomised double blind study on aspirin versus placebo in resected colon cancer with PI3K mutation stage III or II high risk (PRODIGE 50 - ASPIK) | |
| Phase 4Authorised | not given | Randomized clinical trial assessing the value of Beta-Blockers and Antiplatelet Agents in patients with Spontaneous Coronary Artery Dissection (BA-SCAD). | |
| Phase 4Authorised | not given | Antiplatelet Secondary Prevention International Randomised study after INtracerebral haemorrhaGe - SM | |
| Phase 4Authorised | not given | Optimal Antiplatelet Treatment to Achieve Stroke Avoidance and Fall in Bleeding Events following Left Atrial Appendage Closure (SAFE-LAAC). Comparative Health Effectiveness Randomized Trial – PILOT Study | |
| Phase 4Authorised | not given | Optimal Antiplatelet Treatment to Achieve Stroke Avoidance and Fall in Bleeding Events following Left Atrial Appendage Closure – Chronic Kidney Disease (SAFE LAAC CKD). Comparative Health Effectiveness Ancillary Study – PILOT | |
| Phase 3Authorised | not given | CHASAP : Chronic Hypertension and Acetyl Salicylic Acid in Pregnancy, a multicenter prospective randomized double-blind placebo-controlled trial. | |
| Phase 2Authorised | not given | Multicentre, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of low-dose aspirin as an add-on to standard therapy in patients with bipolar disorder (ASPIRIN BD) | |
| Phase 3Authorised | not given | AAS-Lynch - Assessment of the effect of a daily chemoprevention by aspirin low-dose of new or recurrent colorectal adenomas in patients with Lynch syndrome | |
| Phase 3Authorised | not given | COLchicine and non-enteric coated aspirin in the Cardiovascular Outcomes Trial of patients with Type 2 Diabetes (COLCOT-T2D) | |
| Phase 3Ended | not given | A prospective interventional randomized controlled trial to assess the effect of low dose acetylsalicylic acid as a preventive treatment of preeclampsia in pregnant women who underwent frozen embryo transfer | |
| Phase 3Authorised | not given | Prospective Randomized Open-label Trial to Evaluate risk faCTor management in patients with Unruptured intracranial aneurysms (PROTECT-U) | |
| Phase 2Ended | not given | Patient reported efficacy of intranasal lysine-aspirin in controlling NSAID-exacerbated respiratory disease. | |
| Phase 3Authorised | not given | ASPIRIN - Acetylsalicylic acid versus placebo in addition to a local non-steroidal anti-inflammatory drug in the treatment of thrombotic episodes in superficial venous malformations in children aged 6 to 17 years: a controlled randomised, double-blind, cross-over, multicenter trial | |
| Phase 3Authorised | not given | Evaluating oral peri-operative acetylsalicylic acid in subjects undergoing endovascular coiling-only of unruptured brain aneurysms (EVOLVE) | |
| Phase 4Authorised | not given | The safety of ticagrelor monotherapy after primary percutaneous coronary intervention for ST-elevation myocardial infarction and the effect on intramyocardial haemorrhage | |
| Phase 3Ended | not given | Evaluation of safety and efficacy of two ticagrelorbased de-escalation antiplatelet strategies in acute coronary syndrome: the randomized, multicenter, double-blind ELECTRA RCT study. | |
| Phase 4Ended | not given | Genotype-guided strategy for antithrombotic treatment versus conventional clopidogrel therapy in peripheral arterial disease (GENPAD) | |
| Phase 4Authorised | not given | POPular GUILTY PILOT: Genotype-guided Clopidogrel monotherapy | |
| Phase 4Authorised | not given | NOTION-4: Prospective study on the impact of different anti-thrombotic therapies on subclinical leaflet thickening and its temporal dynamics in transcatheter bioprosthetic aortic valves. | |
| Phase 4Ended | not given | PROgnostic value of precision medicine in patients with Myocardial Infarction and non-obStructive coronary artEries: the PROMISE study | |
| Phase 2/3Authorised | not given | NeoAspMet - Neoadjuvant Aspirin and/or Metformin during preoperative induction chemotherapy and chemoradiotherapy for locally-advanced rectal cancer. A multi-arm, multi-stage, intergroup (STAR-04/SICO-CR01/GISCAD/AIRO-GI) randomised clinical trial. The NeoAspMet trial | |
| Phase 4Authorised | not given | Single vs. dual antiplatelet therapy in elderly or HBR patients undergoing percutaneous intervention with drug-coated balloons (PICCOLETO IV-EPIC 38) | |
| Phase 2Authorised | not given | PLatelet aggregation and Aspirin low response in Type One Diabetes and the association with vascular damage and diabetic Nephropathy | |
| Phase 4Authorised | not given | Short-Term Anticoagulation versus Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure. The ANDES study. | |
| Phase 3Authorised | not given | EUROpean pragmatic multicenter randomized trial on platelet inhibition and/or lipid lowering treatment in Covert Brain Infarction (CBI) | |
| Phase 4Authorised | not given | Platelet function testing in outpatients after heart transplantation on aspirin therapy | |
| Phase 3Authorised | not given | Comparing high and lOw-dose asPirin with dual anTIplatelet therapy for three Months using prasUgrel and aSpirin following Coronary Artery Bypass Grafting. (OPTIMUS-CABG trial). | |
| Phase 4Authorised | not given | Tailored antiplatelet secondary prevention in non-cardioembolic ischemic stroke: a phase IV gender-stratified randomized controlled trial (TAILOR trial) | |
| Phase 3/4Authorised | not given | Optimizing Aspirin Use for Preeclampsia Prevention | |
| Phase 3Authorised | not given | Evaluation of an asPirin-free strategy with ticAgrelor in patieNTs witH a myocardial infarction treatEd medically alONe (PANTHEON) | |
| Phase 3/4Authorised | not given | The RELEASE Trial: Reconsidering Long-Term Aspirin in the Elderly in Secondary Prevention of Cardiovascular Disease | |
| Phase 4Authorised | not given | STRategiEs for Antiplatelet Management foLlowIng acute coroNary syndromE (STREAMLINE) | |
| Phase 4Authorised | not given | REconsidering Long-TErm ASpirin in the Elderly in Secondary Prevention of Coronary Artery Disease (RELEASE) Norway: A Randomised, Registry-based Trial |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026